BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 12098702)

  • 1. Reversion of B cell commitment upon loss of Pax5 expression.
    Mikkola I; Heavey B; Horcher M; Busslinger M
    Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.
    Rolink AG; Nutt SL; Melchers F; Busslinger M
    Nature; 1999 Oct; 401(6753):603-6. PubMed ID: 10524629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
    Nutt SL; Heavey B; Rolink AG; Busslinger M
    Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages.
    Hodawadekar S; Yu D; Cozma D; Freedman B; Sunyer O; Atchison ML; Thomas-Tikhonenko A
    Exp Cell Res; 2007 Jan; 313(2):331-40. PubMed ID: 17098231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losing B cell identity.
    Carotta S; Nutt SL
    Bioessays; 2008 Mar; 30(3):203-7. PubMed ID: 18293359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells.
    Delogu A; Schebesta A; Sun Q; Aschenbrenner K; Perlot T; Busslinger M
    Immunity; 2006 Mar; 24(3):269-81. PubMed ID: 16546096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function.
    Fuxa M; Busslinger M
    J Immunol; 2007 Mar; 178(5):3031-7. PubMed ID: 17312149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
    Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
    Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
    Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
    J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF.
    Maeda T; Merghoub T; Hobbs RM; Dong L; Maeda M; Zakrzewski J; van den Brink MR; Zelent A; Shigematsu H; Akashi K; Teruya-Feldstein J; Cattoretti G; Pandolfi PP
    Science; 2007 May; 316(5826):860-6. PubMed ID: 17495164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.
    Cotta CV; Zhang Z; Kim HG; Klug CA
    Blood; 2003 Jun; 101(11):4342-6. PubMed ID: 12560221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembling a gene regulatory network for specification of the B cell fate.
    Medina KL; Pongubala JM; Reddy KL; Lancki DW; Dekoter R; Kieslinger M; Grosschedl R; Singh H
    Dev Cell; 2004 Oct; 7(4):607-17. PubMed ID: 15469848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early function of Pax5 (BSAP) before the pre-B cell receptor stage of B lymphopoiesis.
    Thévenin C; Nutt SL; Busslinger M
    J Exp Med; 1998 Aug; 188(4):735-44. PubMed ID: 9705955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero exposure to alcohol alters cell fate decisions by hematopoietic progenitors in the bone marrow of offspring mice during neonatal development.
    Wang H; Zhou H; Moscatello KM; Dixon C; Brunson LE; Chervenak R; Chervenak DC; Zhao X; Wolcott RM
    Cell Immunol; 2006 Jan; 239(1):75-85. PubMed ID: 16797505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell commitment: Pax5 is the deciding factor.
    Enver T
    Curr Biol; 1999 Dec 16-30; 9(24):R933-5. PubMed ID: 10607584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors.
    Cobaleda C; Jochum W; Busslinger M
    Nature; 2007 Sep; 449(7161):473-7. PubMed ID: 17851532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors.
    Dias S; Silva H; Cumano A; Vieira P
    J Exp Med; 2005 Mar; 201(6):971-9. PubMed ID: 15767371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.
    Heavey B; Charalambous C; Cobaleda C; Busslinger M
    EMBO J; 2003 Aug; 22(15):3887-97. PubMed ID: 12881423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
    Souabni A; Cobaleda C; Schebesta M; Busslinger M
    Immunity; 2002 Dec; 17(6):781-93. PubMed ID: 12479824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.